Maria Horga
Fortune : 448 722 $ au 31/05/2026
Fortune : 448 722 $ au 31/05/2026
Maria Arantxa Horga is currently the Chief Medical Officer at Atea Pharmaceuticals, Inc. She previously worked as the Group Director-Global Clinical Research at Bristol Myers Squibb Co. and as the Head-Translational Medicine at F.
Hoffmann-La Roche Ltd. from 2012 to 2016.
She also served as the Vice President-Pharmacovigilance & Medical Affairs at Biohaven Pharmaceuticals, Inc. from 2019 to 2020, and as the Vice President & Global Head-Clinical Program at Roche Innovation Center from 2017 to 2019.
Dr. Horga obtained her doctorate degree from the University of Santander.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 96 086 ( 0,12% ) | 448 722 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Corporate Officer/Principal | 01/08/2020 |
Roche Innovation Center | Corporate Officer/Principal | 01/08/2019 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
University of Santander
University of Santander Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national